Table 3 Hypertension prevalence, awareness, treatment and control in the intervention and comparison districts
| Â | Comparison | Intervention | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|
N | % | 95% CI | N | % | 95% CI | N | % | 95% CI | |
Examined | 1170 | 100% | Â | 1167 | 100% | Â | 2337 | 100% | Â |
Normal | 805 | 68.8% | (66% – 71.4%) | 785 | 67.3% | (64.5% – 69.9%) | 1590 | 68.0% | (66.1% – 69.9%) |
Stage 1 | 232 | 19.8% | (17.6% – 22.3%) | 210 | 18.0% | (15.9% – 20.3%) | 442 | 18.9% | (17.4% – 20.6%) |
Stage 2 | 86 | 7.4% | (6% – 9%) | 105 | 9.0% | (7.4% – 10.8%) | 191 | 8.2% | (7.1% – 9.4%) |
Stage 3 | 47 | 4.0% | (3% – 5.3%) | 67 | 5.7% | (4.5% – 7.3%) | 114 | 4.9% | (4.1% – 5.9%) |
Examined | 1170 | Â | Â | 1167 | Â | Â | 2337 | Â | Â |
Hypertensive (1) | 367 | 31.4% | (28.7% – 34.1%) | 390 | 33.4% | (30.7% – 36.2%) | 757 | 32.4% | (30.5% – 34.3%) |
Aware (2) | 164 | 44.7% | (39.5% – 49.9%) | 186 | 47.7% | (42.7% – 52.8%) | 350 | 46.2% | (42.6% – 49.9%) |
Treated (2) | 14 | 3.8% | (2.2% – 6.5%) | 17 | 4.4% | (2.6% – 7%) | 31 | 4.1% | (2.8% – 5.8%) |
% of Aware |  | 8.5% | (4.9% – 14.2%) |  | 9.1% | (5.6% – 14.5%) |  | 8.9% | (6.2% – 12.5%) |
Controlled (2) | 2 | 0.5% | (0.1% – 2.2%) | 8 | 2.1% | (1% – 4.2%) | 10 | 1.3% | (0.7% – 2.5%) |
% Treated |  | 14.3% | (2.5% – 43.8%) |  | 47.1% | (23.9% – 71.5%) |  | 32.3% | (17.3% – 51.5%) |